Search Results 1651-1660 of 3949 for Solid

  1. A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis - Mayo Clinic

    A prior solid organ transplant. Presence or history of malignant neoplasm (other than basal or squamous cell skin cancer, insitu carcinomas of the cervix ...

  2. Fernando F. Elli, M.D. - Doctors and Medical Staff - Mayo Clinic

    Foregut surgery · Bariatric surgery · Revisional bariatric surgery · Abdominal wall hernias · Gastroparesis · Solid organ surgery · Minimally invasive and robotic ...

  3. Clinical trials - Oncology (Medical)

    PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors.

  4. Clinical trials - Oncology (Medical)

    PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors.

  5. Publications - Janhavi Athale, M.D. - Mayo Clinic

    Solid organ graft-versus-host disease in a recipient of a COVID-19 positive liver graft. J Liver Transpl. 2023 May; 10:100154 Epub 2023 Apr 19. View PubMed ...

  6. A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) - Mayo Clinic

    Prior solid organ transplant. 6. Infection with human immunodeficiency virus (HIV). 7. Active Hepatitis B or C. This only needs to be excluded in patients ...

  7. Alisertib in Treating Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

    Cohort 5: other sarcomas. Patients must have measurable disease per Response Evaluation Criteria in Solid Tumors(RECIST) 1.1; note: defined as at least one ...

  8. Clinical trials - Oncology (Medical)

    PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors.

  9. CIM CON day 1 - Precision cancer care: 'So much power'

    ... solid tumors. Dr. Lin expects multiple myeloma to be the next cancer type to gain FDA approval for CAR T-cell therapy. "We have a lot to learn," Dr. Lin ...

  10. RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE - Mayo Clinic

    * Solid organ transplant * Bone marrow transplant * Active malignancy undergoing treatment, hospice. Note: Other protocol defined Inclusion/Exclusion ...